Melexis (MELE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Dec, 2025Executive summary
2024 sales were €932.8 million, down 3% year-over-year, with Q4 sales at €197.4 million, a 21% decline year-over-year, mainly due to automotive inventory corrections and order push-outs.
Net income for 2024 was €171.4 million (EPS €4.24–€4.25), down 18% year-over-year; Q4 net income was €18.3 million (EPS €0.45), down 63% year-over-year.
Record product launches and strong design wins in automotive and non-automotive sectors, especially in China, robotics, and electrification applications.
Push order requests and inventory corrections impacted Q4 and are expected to continue into the first half of 2025, with demand recovery anticipated around summer.
Automotive remained the core segment, representing 90% of sales, with balanced design wins across EV, hybrid, and ICE powertrains.
Financial highlights
Full-year 2024 sales: €932.8 million (-3% YoY); Q4 sales: €197.4 million (-21% YoY, -20% QoQ).
Gross margin for 2024: 43% (down from 45.7% in 2023); Q4 gross margin: 39.3% (down from 44.6% in Q4 2023).
Operating income for 2024: €219.9 million (23.6% of sales, -16% YoY); Q4 operating income: €27.6 million (14% of sales, -55% YoY, -57% QoQ).
Net income for 2024: €171.4 million (EPS €4.24–€4.25, -18% YoY); Q4 net income: €18.3 million (EPS €0.45, -63% YoY, -64% QoQ).
Dividend proposal: €3.70 per share for 2024, including €1.30 interim and €2.40 final dividend.
Outlook and guidance
Q1 2025 sales expected at €190–€200 million; H1 2025 sales around €400 million, gross margin near 40%, operating margin around 16%.
Significant sales growth anticipated in H2 2025, driven by stable global automotive production and increasing semiconductor content.
FY 2025 CAPEX expected at €50 million.
Price erosion expected to remain low (2–3%) and manageable, with no major impact on gross margin.
Latest events from Melexis
- 2025 sales fell 10%, profit 34%; Q4 rebounded, 2026 H2 growth and margin recovery expected.MELE
Q4 20254 Feb 2026 - Accelerated innovation, market expansion, and robust financial targets drive future growth.MELE
CMD 20253 Feb 2026 - Q2 2024 sales up 4% year-over-year, with strong margins and lower CAPEX guidance.MELE
Q2 20242 Feb 2026 - Q3 sales steady at €247.9M, but full-year outlook cut amid inventory and market headwinds.MELE
Q3 202417 Jan 2026 - Q1 2025 sales dropped 18% year-over-year, with margins pressured and China strategy advancing.MELE
Q1 202524 Dec 2025 - Q3 sales reached €215.3M, down 13% year-over-year, with gross margin at 38.8%.MELE
Q3 202529 Oct 2025 - Sequential sales and margin growth in Q2 2025, with full-year outlook reaffirmed.MELE
Q2 202530 Jul 2025